Latest Commercialisation News

Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.

Firebrick Pharma has made notable progress expanding its Nasodine nasal spray in Singapore, securing major distribution and marketing agreements that set the stage for retail sales growth in 2025.

Vulcan Energy has successfully closed its Share Purchase Plan, raising approximately A$8 million through the issuance of over 1.3 million new shares, following a major institutional placement. This capital injection supports the company’s pioneering lithium and renewable energy projects in Europe.

Archer Materials has been granted a pivotal US patent for its Biochip technology, safeguarding its intellectual property and positioning the company for strategic entry into the lucrative US medical diagnostics market.

LTR Pharma has inked a national distribution agreement with Symbion, positioning its innovative ED treatment SPONTAN® for broad pharmacy access across Australia ahead of its commercial launch.

Zoono Group reports expanding global trials of its shelf-life extension technology, engaging over 40 supermarket and packaging companies, while refining its product and managing cash flow amid cautious commercial adoption.

Thrive Tribe Technologies has appointed Jade Spooner as CEO to spearhead the rapid commercialisation of its Kumu platform and e-commerce marketplace. Spooner’s proven track record in scaling tech startups positions her to lead 1TT into its next growth phase.

NOVONIX announces the departure of CEO Dr. Chris Burns, with CFO Robert Long stepping in as interim CEO amid plans to scale production at its Riverside facility.

Wesfarmers has announced the wind down of Catch as a standalone business, transferring its e-commerce fulfilment centres to Kmart Group and integrating key digital capabilities into its retail divisions to strengthen omnichannel offerings.

Hazer Group has successfully completed its Commercial Demonstration Plant program ahead of schedule, validating its methane pyrolysis technology and securing significant funding to accelerate commercialisation in 2025.

Connexion Mobility reports robust Q2 FY25 results with revenue and net profit surging, driven by subscription growth and strategic product launches. The company’s focus on user engagement and marketplace expansion signals promising long-term shareholder value.

Medallion Metals Limited has intersected substantial semi-massive to massive sulphides in its latest diamond drilling at the Trilogy Deposit, setting the stage for potential commercialisation via existing Forrestania infrastructure.